ACTUAL: Efficacy and Safety of Irbesartan/Hydrochlorothiazide Combination
Status:
Completed
Trial end date:
2009-07-01
Target enrollment:
Participant gender:
Summary
To compare the antihypertensive efficacy of the combination irbesartan/hydrochlorothiazide
(HCTZ) using either a usual or an active elective titration regimen. The main efficacy
criteria will be the change in mean Systolic Blood Pressure (SBP), measured at doctor's
office with an automatic device, after a 10-week treatment period in hypertensive patients
insufficiently controlled by monotherapy.